Hannah C Bergo

2PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 07, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.

Tadashi Manabe, Hannah C Bergo, Qingtian Li

|Mar 07, 2025
Condensates as a Culprit in RAS Activation and Inhibitor Resistance.

Hannah C Bergo, Logan B Leak, Trever G Bivona

Pageof 1

Frequent Collaborators

2 joint publications

Trever G Bivona

1 joint publications

Logan B Leak

1 joint publications

Tadashi Manabe

1 joint publications

Paul Severson

1 joint publications

Catherine Lee

1 joint publications

Nicole Zhang

1 joint publications

Wei Wu

1 joint publications

Kathryn B Grandinetti

1 joint publications

Joel W Neal

1 joint publications

Shumei Kato

Frequent Collaborators

2 joint publications

Trever G Bivona

1 joint publications

Logan B Leak

1 joint publications

Tadashi Manabe

1 joint publications

Paul Severson

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.6K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

6.0K
See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.6K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

6.0K
See more related videos